145 related articles for article (PubMed ID: 35911136)
1. High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.
Bao Z; Zhang Y; Yu P; Wang Y; Hu C; Xia Y; Yuan L; Xu Z; Cheng X
Evid Based Complement Alternat Med; 2022; 2022():1323321. PubMed ID: 35911136
[TBL] [Abstract][Full Text] [Related]
2. Histone chaperone CHAF1A impacts the outcome of fluoropyrimidines-based adjuvant therapy in gastric cancer by regulating the expression of thymidylate synthetase.
Wang D; Li X; Shen B; Chen X; Shu Y
Gene; 2019 Oct; 716():144034. PubMed ID: 31377317
[TBL] [Abstract][Full Text] [Related]
3. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
6. A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
Li XN; Peng YH; Yue W; Tao L; Zhang WJ
PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
[TBL] [Abstract][Full Text] [Related]
7. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression.
Zheng L; Liang X; Li S; Li T; Shang W; Ma L; Jia X; Shao W; Sun P; Chen C; Jia J
EBioMedicine; 2018 Dec; 38():69-78. PubMed ID: 30449701
[TBL] [Abstract][Full Text] [Related]
8. High
Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of PD‑L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer.
Zou Y; Wang J; Zhang J; Guo Q; Song Z; Tang H
Oncol Lett; 2024 Jan; 27(1):20. PubMed ID: 38058467
[TBL] [Abstract][Full Text] [Related]
10. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
11. Programmed Death-Ligand 1 (PD-L1) Positivity and Factors Associated with Poor Prognosis in Patients with Gastric Cancer: An Umbrella Meta-Analysis.
Hassen G; Kasar A; Jain N; Berry S; Dave J; Zouetr M; Priyanka Ganapathiraju VLN; Kurapati T; Oshai S; Saad M; Pathan J; Kamat S; Tirupathi R; Patel UK; Rana RK
Cureus; 2022 Apr; 14(4):e23845. PubMed ID: 35530821
[TBL] [Abstract][Full Text] [Related]
12. An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.
Ying L; Hu Z; Lu Y; Tao Q; Xiong F; Shu Y; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Xu M; Li X; Wang D
Oncoimmunology; 2024; 13(1):2303195. PubMed ID: 38235318
[TBL] [Abstract][Full Text] [Related]
13. CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients.
Li X; Chen L; Gu C; Sun Q; Li J
PeerJ; 2020; 8():e9536. PubMed ID: 32874775
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneity of PD-L1 protein in gastric cancer: expression and distribution characteristics.
Wang Y; Wang N; Huang Z; Lu Z; Guo T; Meng G
Heliyon; 2022 Dec; 8(12):e12456. PubMed ID: 36593830
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.
Ito S; Fukagawa T; Noda M; Hu Q; Nambara S; Shimizu D; Kuroda Y; Eguchi H; Masuda T; Sato T; Katai H; Sasako M; Mimori K
Ann Surg Oncol; 2018 Nov; 25(12):3755-3763. PubMed ID: 30203407
[TBL] [Abstract][Full Text] [Related]
16. Programmed death-1 and PD-1 ligand-1 expression in early onset gastric carcinoma and correlation with clinicopathological characteristics.
Wei P; Jin M; Zhou X; Hu X; Wang Y
Int J Clin Exp Pathol; 2018; 11(4):1989-1998. PubMed ID: 31938305
[No Abstract] [Full Text] [Related]
17. Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer.
Lv H; Zhang J; Sun K; Nie C; Chen B; Wang J; Xu W; Wang S; Liu Y; Chen X
Front Oncol; 2020; 10():580045. PubMed ID: 33598422
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target.
Cao J; Hu C; Xu J; Han J; Zhang R; Cao M; Yuan L; Xu Z
Evid Based Complement Alternat Med; 2022; 2022():4257342. PubMed ID: 36082181
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance.
Sun X; Ma Q; Cheng Y; Huang H; Qin J; Zhang M; Qu S
Front Genet; 2023; 14():1108004. PubMed ID: 36968583
[No Abstract] [Full Text] [Related]
20. Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer.
Zhang C; Zhao S; Wang X
Cancer Cell Int; 2021 Jan; 21(1):78. PubMed ID: 33509216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
